Patents by Inventor Benjamin Gillet

Benjamin Gillet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7910522
    Abstract: The present invention relates to methods for the identification or cloning of polynucleotides encoding a selected phenotype, particularly from environmental DNA. In a specific embodiment, the method comprises (i) cloning environmental DNA fragments into E. coli cloning vectors to produce a metagenomic library, (ii) identifying or selecting cloning vectors in the library which contain DNA fragments having a particular characteristic of interest, (iii) modifying the identified or selected cloning vectors into shuttle or expression vectors for transfer and integration in a selected host cell, (iv) transferring the modified cloning vectors into the selected host-cell and (v) identifying or cloning the DNA fragments contained in the modified cloning vectors which encode the selected phenotype in the selected host cell.
    Type: Grant
    Filed: July 17, 2003
    Date of Patent: March 22, 2011
    Assignee: Libragen
    Inventors: Renaud Nalin, Petar Pujic, Karine Tuphile, Benjamin Gillet
  • Publication number: 20100323390
    Abstract: The invention relates to the direct selection of metabolic pathways having a determined function in the transformation of a substrate {Ai} into a target product {B}, which is of interest in the industrial, pharmaceutical or agri-food sectors. More specifically, the invention relates to the detection, within metagenomic libraries, of novel biosynthesis pathways involved in a biochemical reaction having a known product {B}. The selection and characterisation of said novel metabolic pathways enables {B} to be produced enzymatically. The invention provides an alternative to the chemical synthesis of the molecule in question {B}. Moreover, and above all, the invention can be used specifically to target and exploit the only metabolic pathways enabling the transformation of {Ai} into {B}, while eliminating the associated metabolic pathways that can catabolise the target product {B}.
    Type: Application
    Filed: August 31, 2010
    Publication date: December 23, 2010
    Applicant: LIBRAGEN
    Inventors: Pierre Monsan, Claude Bensoussan, Philippe Reulet, Renaud Nalin, Patrick Robe, Karine Tuphile, Benjamin Gillet, Pierre Pujic
  • Patent number: 7846874
    Abstract: The invention relates to the direct selection of metabolic pathways having a determined function in the transformation of a substrate {Ai} into a target product {B}, which is of interest in the industrial, pharmaceutical or agri-food sectors. More specifically, the invention relates to the detection, within metagenomic libraries, of novel biosynthesis pathways involved in a biochemical reaction having a known product {B}. The selection and characterization of said novel metabolic pathways enables {B} to be produced enzymatically. The invention provides an alternative to the chemical synthesis of the molecule in question {B}. Moreover, and above all, the invention can be used specifically to target and exploit the only metabolic pathways enabling the transformation of {Ai} into {B}, while eliminating the associated metabolic pathways that can catabolise the target product {B}.
    Type: Grant
    Filed: March 22, 2005
    Date of Patent: December 7, 2010
    Assignee: Libragen
    Inventors: Pierre Monsan, Claude Bensoussan, Philippe Reulet, Renaud Nalin, Patrick Robe, Karine Tuphile, Benjamin Gillet, Pierre Pujic
  • Publication number: 20070184449
    Abstract: The invention relates to the direct selection of metabolic pathways having a determined function in the transformation of a substrate {Ai} into a target product {B}, which is of interest in the industrial, pharmaceutical or agri-food sectors. More specifically, the invention relates to the detection, within metagenomic libraries, of novel biosynthesis pathways involved in a biochemical reaction having a known product {B}. The selection and characterisation of said novel metabolic pathways enables {B} to be produced enzymatically. The invention provides an alternative to the chemical synthesis of the molecule in question {B}. Moreover, and above all, the invention can be used specifically to target and exploit the only metabolic pathways enabling the transformation of {Ai} into {B}, while eliminating the associated metabolic pathways that can catabolise the target product {B}.
    Type: Application
    Filed: March 22, 2005
    Publication date: August 9, 2007
    Inventors: Pierre Monsan, Claude Bensoussan, Philippe Reulet, Renaud Nalin, Patrick Robe, Karine Tuphile, Benjamin Gillet, Pierre Pujic
  • Publication number: 20050282166
    Abstract: The present invention relates to methods for the identification or cloning of polynucleotides encoding a selected phenotype, particularly from environmental DNA. In a specific embodiment, the method comprises (i) cloning environmental DNA fragments into E coli cloning vectors to produce a metagenomic library, (ii) identifying or selecting cloning vectors in said library which contain DNA fragments having a particular characteristic of interest, (iii) modifying the identified or selected cloning vectors into shuttle or expression vectors for transfer and integration in a selected host cell, (iv) transferring the modified cloning vectors into said selected host-cell and (v) identifying or cloning the DNA fragments contained in said modified cloning vectors which encode said selected phenotype in said selected host cell.
    Type: Application
    Filed: July 17, 2003
    Publication date: December 22, 2005
    Inventors: Renaud Nalin, Petar Pujic, Karine Tuphile, Benjamin Gillet